Let's face it, risk is a difficult topic;
thinking about things that can go wrong is stressful!
Managing risks in medical device clinical trial projects can
seem daunting, with so many aspects to consider: patient
enrollment behind schedule, delays in delivery of study
supplies, and more. The clinical trial manager may also need
to participate in the product risk management process for
the device under study (per ISO 14971), which incorporates
clinical evidence from these trials - that process can seem
complex to those unfamiliar with it. These 2 risk management
processes may seem different, but are in fact grounded in
the same basic risk management framework and can be executed
with a logical thought process.
These topics are integrated and explored by PMINJ Life
Sciences LCI Chairperson Claudia Campbell-Matland in her
article “Managing Risks for Medical Device Clinical Trials
and their (Medical Devices) Products” (published September
2018 in MedDevice Online and August 2020 in Society of
Clinical Research Associates’ SOURCE Journal). This
Life Sciences LCI virtual event will be an informal
discussion - registrants
should
download the article to read prior to the event,
and be able to discuss it with Claudia via Zoom Q&A.
Bring your questions and be prepared for a lively discussion
on risk!